MENU

EXEL Exelixis Forecast, Technical & Fundamental Analysis

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology
EXEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
EXEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EXEL is expected to report earnings to fall 33.32% to 31 cents per share on February 11

Exelixis EXEL Stock Earnings Reports
Q4'24
Est.
$0.31
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.53
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.10
The last earnings report on October 29 showed earnings per share of 46 cents, beating the estimate of 34 cents. With 883.33K shares outstanding, the current market capitalization sits at 10.01B.
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

EXEL and Stocks

Correlation & Price change

A.I.dvisor tells us that EXEL and RIGL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXEL and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
-0.40%
RIGL - EXEL
29%
Poorly correlated
+0.18%
RVMD - EXEL
28%
Poorly correlated
-1.31%
ALGS - EXEL
27%
Poorly correlated
-0.61%
RARE - EXEL
27%
Poorly correlated
-2.20%
PLX - EXEL
27%
Poorly correlated
+13.71%
More

Groups containing EXEL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
-0.40%
modules
theme (9 stocks)
25%
Poorly correlated
-3.68%
cancer
theme (82 stocks)
24%
Poorly correlated
-5.37%
drugs
theme (254 stocks)
23%
Poorly correlated
-4.03%
treatment
theme (56 stocks)
17%
Poorly correlated
-4.29%
biotechnology
theme (238 stocks)
16%
Poorly correlated
-4.32%